These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6981516)

  • 1. Differential actions of calcium antagonists on calcium binding to cardiac sarcolemma.
    Pang DC; Sperelakis N
    Eur J Pharmacol; 1982 Jul; 81(3):403-9. PubMed ID: 6981516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory action of bepridil (CERM-1978) on calcium binding to cardiac sarcolemma of guinea pig.
    Pang DC; Sperelakis N
    Biochem Pharmacol; 1981 Aug; 30(16):2356-8. PubMed ID: 6975102
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacology of calcium antagonists.
    Schwartz A; Matlib MA; Balwierczak J; Lathrop DA
    Am J Cardiol; 1985 Mar; 55(7):3C-7C. PubMed ID: 3872055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the mechanism of negative inotropic activity of some calcium antagonists.
    Boddeke HW; Wilffert B; Heynis JB; van Zwieten PA
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):321-5. PubMed ID: 2452925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nifedipine, diltiazem, bepridil and verapamil uptakes into cardiac and smooth muscles.
    Pang DC; Sperelakis N
    Eur J Pharmacol; 1983 Feb; 87(2-3):199-207. PubMed ID: 6601581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of bepridil, diltiazem, nifedipine and verapamil on haemodynamic parameters and myocardial oxygen consumption in anaesthetized dogs.
    Beaughard M; Michelin MT; Tisne-Versailles J; Lamar JC
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):276-96. PubMed ID: 3493742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the cardiac and vasodilatory effects of some calcium entry blockers in perfused isolated guinea-pig hearts.
    Boddeke HW; Wilffert B; Heynis JB; van de Haar Keuken V; Jonkman FA; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):175-85. PubMed ID: 3675080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of five different organic calcium antagonists on guinea-pig isolated trachea.
    Advenier C; Cerrina J; Duroux P; Floch A; Renier A
    Br J Pharmacol; 1984 Jul; 82(3):727-33. PubMed ID: 6611187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase.
    Lamers JM; Cysouw KJ; Verdouw PD
    Biochem Pharmacol; 1985 Nov; 34(21):3837-43. PubMed ID: 2933041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca2+-antagonists inhibit the N-methyltransferase-dependent synthesis of phosphatidylcholine in the heart.
    Tappia PS; Okumura K; Kawabata K; Shah KR; Nijjar MS; Panagia V; Dhalla NS
    Mol Cell Biochem; 2001 May; 221(1-2):89-98. PubMed ID: 11506191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression of contractions of rabbit aorta and guinea pig vena cava by mesudipine and other slow channel blockers.
    Sperelakis N; Mras S
    Blood Vessels; 1983; 20(4):172-83. PubMed ID: 6601967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between the binding site of [3H]-d-cis-diltiazem and that of other non-dihydropyridine calcium entry blockers in cardiac sarcolemma.
    Balwierczak JL; Johnson CL; Schwartz A
    Mol Pharmacol; 1987 Feb; 31(2):175-9. PubMed ID: 2433570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nifedipine, verapamil, and diltiazem on [3H]-nitrendipine binding to the purified canine cardiac sarcolemmal membrane.
    Kurobe Y; Ishii K; Kano T; Ando J
    Bull Osaka Med Sch; 1985 Jul; 31(1):1-14. PubMed ID: 3026536
    [No Abstract]   [Full Text] [Related]  

  • 15. Uptake of calcium antagonistic drugs into muscles as related to their lipid solubilities.
    Pang DC; Sperelakis N
    Biochem Pharmacol; 1984 Mar; 33(5):821-6. PubMed ID: 6608945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential potentiation by depolarization of the effects of calcium antagonists on contraction and Ca2+ current in guinea-pig heart.
    Okuyama R; Adachi-Akahane S; Nagao T
    Br J Pharmacol; 1994 Oct; 113(2):451-6. PubMed ID: 7834195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.
    Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-dependent effects of bepridil on Ca2+-extrusion across rat heart sarcolemma.
    Van Amsterdam FT; Zaagsma J
    Arch Int Pharmacodyn Ther; 1989; 298():90-5. PubMed ID: 2787975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca2+ uptake and energy supply of sheep heart mitochondria in presence of some calcium antagonists.
    Leblondel G; Allain P
    Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):499-502. PubMed ID: 6611569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bepridil and diltiazem on [3H]nitrendipine binding to canine cardiac sarcolemma. Potentiation of pharmacological effects of nitrendipine by bepridil.
    Balwierczak JL; Grupp IL; Grupp G; Schwartz A
    J Pharmacol Exp Ther; 1986 Apr; 237(1):40-8. PubMed ID: 2937911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.